MARKER THERAPEUTICS, INC.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $183.1K |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $5.3M |
| SG&A Expense | $6.4M |
| Operating Income | $-11.5M |
| Operating Margin | -6,271.1% |
| Interest Expense | — |
| Pretax Income | — |
| Income Tax Expense | $0 |
| Net Income | $-11.0M |
| Net Margin | -5,999.1% |
| EPS (Basic) | $-0.29 |
| EPS (Diluted) | $-0.29 |
| Shares Outstanding (Basic) | 37.8M |
| Shares Outstanding (Diluted) | 37.8M |
| Dividends Per Share | — |